Global Liquid Biopsy Market Size study & Forecast, by Product and Services (Kits & Reagents, Platforms & Instruments, Services) by Circulating Biomarker (Circulating Tumor Cells, Extracellular Vesicles, Circulating Tumor DNA [ctDNA], Other Biomarkers), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Other Cancers), by End-user (Hospitals & Laboratories and Government & Academic Research Centers) and Regional Analysis, 2023-2030
Global Liquid Biopsy Market is valued at approximately USD 4.30 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 18.50% over the forecast period 2023-2030. The global liquid biopsy market refers to the market for diagnostic tests that detect cancer and other diseases by analyzing genetic material or biomarkers in bodily fluids such as blood, urine, and cerebrospinal fluid. Liquid biopsy tests are non-invasive and provide a less expensive and less risky alternative to traditional tissue biopsies, which involve the removal of tissue samples from the body. The major driving factors for the Global Liquid Biopsy Market are the increasing prevalence of cancer and the growing demand for non-invasive diagnostic tests. Moreover, rising technological advancements and increasing investment in research and development are creating lucrative growth opportunities for the market over the forecast period 2023-2030.
Companies and research institutions are investing heavily in research and development to improve the sensitivity, specificity, and accuracy of liquid biopsy tests, which is driving innovation in the field. For instance, in 2020, Guardant Health invested USD 100 million in a new research and development facility focused on liquid biopsy technology. The company has also announced plans to develop new liquid biopsy tests for use in cancer diagnosis and treatment. Similarly, Grail, a leading liquid biopsy company, has raised over USD 6 billion in funding since 2020, with a significant portion of this investment dedicated to research and development. The company has developed a multi-cancer early-detection test and is currently conducting clinical trials to validate its efficacy. However, the high cost of Liquid Biopsy stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Liquid Biopsy Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is the largest market for liquid biopsy, driven by the presence of several key players in the region, as well as a favorable regulatory environment for the development and commercialization of new technologies. The United States is the biggest contributor to the growth of the North American liquid biopsy market. Asia Pacific is a rapidly growing market for liquid biopsy, driven by the increasing prevalence of cancer in the region and a growing focus on personalized medicine. Countries such as China, Japan, and India are expected to be major contributors to the growth of the Asia Pacific liquid biopsy market.
Major market player included in this report are:
Guardant Health
Grail
Illumina, Inc
Freenome
Biocept, Inc
Natera, Inc.
Cardiff OncologyRainDance Technologies
Adaptive Biotechnologies
Exosome Diagnostics, Inc.
Recent Developments in the Market:
In November 2021, Grail announced the launch of its large-scale clinical trial, the Circulating Cell-Free Genome Atlas (CCGA) study, which aims to validate the effectiveness of its liquid biopsy technology for the early detection of cancer.
In August 2020, Guardant Health announced the launch of its liquid biopsy test, Guardant360 CDx, which can detect multiple cancer biomarkers in a single blood sample.
Global Liquid Biopsy Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product and Services, Circulating Biomarker, Cancer Type, End-user, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product and Services offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product and Services:
Kits & Reagents
Platforms & Instruments
Services
By Circulating Biomarker:
Circulating Tumor Cells
Extracellular Vesicles
Circulating Tumor DNA [ctDNA]
Other Biomarkers
By Cancer Type:
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Liver Cancer
Other Cancers ?
By End-user:
Hospitals & Laboratories
Government & Academic Research Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Companies and research institutions are investing heavily in research and development to improve the sensitivity, specificity, and accuracy of liquid biopsy tests, which is driving innovation in the field. For instance, in 2020, Guardant Health invested USD 100 million in a new research and development facility focused on liquid biopsy technology. The company has also announced plans to develop new liquid biopsy tests for use in cancer diagnosis and treatment. Similarly, Grail, a leading liquid biopsy company, has raised over USD 6 billion in funding since 2020, with a significant portion of this investment dedicated to research and development. The company has developed a multi-cancer early-detection test and is currently conducting clinical trials to validate its efficacy. However, the high cost of Liquid Biopsy stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Liquid Biopsy Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is the largest market for liquid biopsy, driven by the presence of several key players in the region, as well as a favorable regulatory environment for the development and commercialization of new technologies. The United States is the biggest contributor to the growth of the North American liquid biopsy market. Asia Pacific is a rapidly growing market for liquid biopsy, driven by the increasing prevalence of cancer in the region and a growing focus on personalized medicine. Countries such as China, Japan, and India are expected to be major contributors to the growth of the Asia Pacific liquid biopsy market.
Major market player included in this report are:
Guardant Health
Grail
Illumina, Inc
Freenome
Biocept, Inc
Natera, Inc.
Cardiff OncologyRainDance Technologies
Adaptive Biotechnologies
Exosome Diagnostics, Inc.
Recent Developments in the Market:
In November 2021, Grail announced the launch of its large-scale clinical trial, the Circulating Cell-Free Genome Atlas (CCGA) study, which aims to validate the effectiveness of its liquid biopsy technology for the early detection of cancer.
In August 2020, Guardant Health announced the launch of its liquid biopsy test, Guardant360 CDx, which can detect multiple cancer biomarkers in a single blood sample.
Global Liquid Biopsy Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product and Services, Circulating Biomarker, Cancer Type, End-user, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product and Services offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product and Services:
Kits & Reagents
Platforms & Instruments
Services
By Circulating Biomarker:
Circulating Tumor Cells
Extracellular Vesicles
Circulating Tumor DNA [ctDNA]
Other Biomarkers
By Cancer Type:
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Liver Cancer
Other Cancers ?
By End-user:
Hospitals & Laboratories
Government & Academic Research Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Liquid Biopsy Market, by Region, 2020-2030 (USD Billion)
1.2.2. Liquid Biopsy Market, by Product and Services, 2020-2030 (USD Billion)
1.2.3. Liquid Biopsy Market, by Circulating Biomarker, 2020-2030 (USD Billion)
1.2.4. Liquid Biopsy Market, by Cancer Type, 2020-2030 (USD Billion)
1.2.5. Liquid Biopsy Market, by End-user, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL LIQUID BIOPSY MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL LIQUID BIOPSY MARKET DYNAMICS
3.1. Liquid Biopsy Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of cancer
3.1.1.2. Growing demand for non-invasive diagnostic tests
3.1.2. Market Challenges
3.1.2.1. High Cost of Liquid Biopsy
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Rising initiatives by key market players
CHAPTER 4. GLOBAL LIQUID BIOPSY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT AND SERVICES
5.1. Market Snapshot
5.2. Global Liquid Biopsy Market by Product and Services, Performance - Potential Analysis
5.3. Global Liquid Biopsy Market Estimates & Forecasts by Product and Services 2020-2030 (USD Billion)
5.4. Liquid Biopsy Market, Sub Segment Analysis
5.4.1. Kits & Reagents
5.4.2. Platforms & Instruments
5.4.3. Services
CHAPTER 6. GLOBAL LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER
6.1. Market Snapshot
6.2. Global Liquid Biopsy Market by Circulating Biomarker, Performance - Potential Analysis
6.3. Global Liquid Biopsy Market Estimates & Forecasts by Circulating Biomarker 2020-2030 (USD Billion)
6.4. Liquid Biopsy Market, Sub Segment Analysis
6.4.1. Circulating Tumor Cells
6.4.2. Extracellular Vesicles
6.4.3. Circulating Tumor DNA [ctDNA]
6.4.4. Other Biomarkers
CHAPTER 7. GLOBAL LIQUID BIOPSY MARKET, BY CANCER TYPE
7.1. Market Snapshot
7.2. Global Liquid Biopsy Market by Cancer Type, Performance - Potential Analysis
7.3. Global Liquid Biopsy Market Estimates & Forecasts by Cancer Type 2020-2030 (USD Billion)
7.4. Liquid Biopsy Market, Sub Segment Analysis
7.4.1. Lung Cancer
7.4.2. Breast Cancer
7.4.3. Colorectal Cancer
7.4.4. Prostate Cancer
7.4.5. Liver Cancer
7.4.6. Other Cancers
CHAPTER 8. GLOBAL LIQUID BIOPSY MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Liquid Biopsy Market by End-user, Performance - Potential Analysis
8.3. Global Liquid Biopsy Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
8.4. Liquid Biopsy Market, Sub Segment Analysis
8.4.1. Hospitals & Laboratories
8.4.2. Government & Academic Research Centers
CHAPTER 9. GLOBAL LIQUID BIOPSY MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Liquid Biopsy Market, Regional Market Snapshot
9.4. North America Liquid Biopsy Market
9.4.1. U.S. Liquid Biopsy Market
9.4.1.1. Product and Services breakdown estimates & forecasts, 2020-2030
9.4.1.2. Circulating Biomarker breakdown estimates & forecasts, 2020-2030
9.4.1.3. Cancer Type breakdown estimates & forecasts, 2020-2030
9.4.1.4. End-user breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Liquid Biopsy Market
9.5. Europe Liquid Biopsy Market Snapshot
9.5.1. U.K. Liquid Biopsy Market
9.5.2. Germany Liquid Biopsy Market
9.5.3. France Liquid Biopsy Market
9.5.4. Spain Liquid Biopsy Market
9.5.5. Italy Liquid Biopsy Market
9.5.6. Rest of Europe Liquid Biopsy Market
9.6. Asia-Pacific Liquid Biopsy Market Snapshot
9.6.1. China Liquid Biopsy Market
9.6.2. India Liquid Biopsy Market
9.6.3. Japan Liquid Biopsy Market
9.6.4. Australia Liquid Biopsy Market
9.6.5. South Korea Liquid Biopsy Market
9.6.6. Rest of Asia Pacific Liquid Biopsy Market
9.7. Latin America Liquid Biopsy Market Snapshot
9.7.1. Brazil Liquid Biopsy Market
9.7.2. Mexico Liquid Biopsy Market
9.8. Middle East & Africa Liquid Biopsy Market
9.8.1. Saudi Arabia Liquid Biopsy Market
9.8.2. South Africa Liquid Biopsy Market
9.8.3. Rest of Middle East & Africa Liquid Biopsy Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Guardant Health
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Grail
10.3.3. Illumina , Inc
10.3.4. Freenome
10.3.5. Biocept , Inc
10.3.6. Natera , Inc.
10.3.7. Cardiff OncologyTrovagene
10.3.8. RainDance Technologies
10.3.9. Adaptive Biotechnologies
10.3.10. Exosome Diagnostics , Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Liquid Biopsy Market, by Region, 2020-2030 (USD Billion)
1.2.2. Liquid Biopsy Market, by Product and Services, 2020-2030 (USD Billion)
1.2.3. Liquid Biopsy Market, by Circulating Biomarker, 2020-2030 (USD Billion)
1.2.4. Liquid Biopsy Market, by Cancer Type, 2020-2030 (USD Billion)
1.2.5. Liquid Biopsy Market, by End-user, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL LIQUID BIOPSY MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL LIQUID BIOPSY MARKET DYNAMICS
3.1. Liquid Biopsy Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of cancer
3.1.1.2. Growing demand for non-invasive diagnostic tests
3.1.2. Market Challenges
3.1.2.1. High Cost of Liquid Biopsy
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Rising initiatives by key market players
CHAPTER 4. GLOBAL LIQUID BIOPSY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT AND SERVICES
5.1. Market Snapshot
5.2. Global Liquid Biopsy Market by Product and Services, Performance - Potential Analysis
5.3. Global Liquid Biopsy Market Estimates & Forecasts by Product and Services 2020-2030 (USD Billion)
5.4. Liquid Biopsy Market, Sub Segment Analysis
5.4.1. Kits & Reagents
5.4.2. Platforms & Instruments
5.4.3. Services
CHAPTER 6. GLOBAL LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER
6.1. Market Snapshot
6.2. Global Liquid Biopsy Market by Circulating Biomarker, Performance - Potential Analysis
6.3. Global Liquid Biopsy Market Estimates & Forecasts by Circulating Biomarker 2020-2030 (USD Billion)
6.4. Liquid Biopsy Market, Sub Segment Analysis
6.4.1. Circulating Tumor Cells
6.4.2. Extracellular Vesicles
6.4.3. Circulating Tumor DNA [ctDNA]
6.4.4. Other Biomarkers
CHAPTER 7. GLOBAL LIQUID BIOPSY MARKET, BY CANCER TYPE
7.1. Market Snapshot
7.2. Global Liquid Biopsy Market by Cancer Type, Performance - Potential Analysis
7.3. Global Liquid Biopsy Market Estimates & Forecasts by Cancer Type 2020-2030 (USD Billion)
7.4. Liquid Biopsy Market, Sub Segment Analysis
7.4.1. Lung Cancer
7.4.2. Breast Cancer
7.4.3. Colorectal Cancer
7.4.4. Prostate Cancer
7.4.5. Liver Cancer
7.4.6. Other Cancers
CHAPTER 8. GLOBAL LIQUID BIOPSY MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Liquid Biopsy Market by End-user, Performance - Potential Analysis
8.3. Global Liquid Biopsy Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
8.4. Liquid Biopsy Market, Sub Segment Analysis
8.4.1. Hospitals & Laboratories
8.4.2. Government & Academic Research Centers
CHAPTER 9. GLOBAL LIQUID BIOPSY MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Liquid Biopsy Market, Regional Market Snapshot
9.4. North America Liquid Biopsy Market
9.4.1. U.S. Liquid Biopsy Market
9.4.1.1. Product and Services breakdown estimates & forecasts, 2020-2030
9.4.1.2. Circulating Biomarker breakdown estimates & forecasts, 2020-2030
9.4.1.3. Cancer Type breakdown estimates & forecasts, 2020-2030
9.4.1.4. End-user breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Liquid Biopsy Market
9.5. Europe Liquid Biopsy Market Snapshot
9.5.1. U.K. Liquid Biopsy Market
9.5.2. Germany Liquid Biopsy Market
9.5.3. France Liquid Biopsy Market
9.5.4. Spain Liquid Biopsy Market
9.5.5. Italy Liquid Biopsy Market
9.5.6. Rest of Europe Liquid Biopsy Market
9.6. Asia-Pacific Liquid Biopsy Market Snapshot
9.6.1. China Liquid Biopsy Market
9.6.2. India Liquid Biopsy Market
9.6.3. Japan Liquid Biopsy Market
9.6.4. Australia Liquid Biopsy Market
9.6.5. South Korea Liquid Biopsy Market
9.6.6. Rest of Asia Pacific Liquid Biopsy Market
9.7. Latin America Liquid Biopsy Market Snapshot
9.7.1. Brazil Liquid Biopsy Market
9.7.2. Mexico Liquid Biopsy Market
9.8. Middle East & Africa Liquid Biopsy Market
9.8.1. Saudi Arabia Liquid Biopsy Market
9.8.2. South Africa Liquid Biopsy Market
9.8.3. Rest of Middle East & Africa Liquid Biopsy Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Guardant Health
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Grail
10.3.3. Illumina , Inc
10.3.4. Freenome
10.3.5. Biocept , Inc
10.3.6. Natera , Inc.
10.3.7. Cardiff OncologyTrovagene
10.3.8. RainDance Technologies
10.3.9. Adaptive Biotechnologies
10.3.10. Exosome Diagnostics , Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Liquid Biopsy Market, report scope
TABLE 2. Global Liquid Biopsy Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Liquid Biopsy Market estimates & forecasts by Product and Services 2020-2030 (USD Billion)
TABLE 4. Global Liquid Biopsy Market estimates & forecasts by Circulating Biomarker 2020-2030 (USD Billion)
TABLE 5. Global Liquid Biopsy Market estimates & forecasts by Cancer Type 2020-2030 (USD Billion)
TABLE 6. Global Liquid Biopsy Market estimates & forecasts by End-user 2020-2030 (USD Billion)
TABLE 7. Global Liquid Biopsy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Liquid Biopsy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Liquid Biopsy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Liquid Biopsy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Liquid Biopsy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Liquid Biopsy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Liquid Biopsy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Liquid Biopsy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Liquid Biopsy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Liquid Biopsy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Liquid Biopsy Market
TABLE 72. List of primary sources, used in the study of global Liquid Biopsy Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Liquid Biopsy Market, report scope
TABLE 2. Global Liquid Biopsy Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Liquid Biopsy Market estimates & forecasts by Product and Services 2020-2030 (USD Billion)
TABLE 4. Global Liquid Biopsy Market estimates & forecasts by Circulating Biomarker 2020-2030 (USD Billion)
TABLE 5. Global Liquid Biopsy Market estimates & forecasts by Cancer Type 2020-2030 (USD Billion)
TABLE 6. Global Liquid Biopsy Market estimates & forecasts by End-user 2020-2030 (USD Billion)
TABLE 7. Global Liquid Biopsy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Liquid Biopsy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Liquid Biopsy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Liquid Biopsy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Liquid Biopsy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Liquid Biopsy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Liquid Biopsy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Liquid Biopsy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Liquid Biopsy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Liquid Biopsy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Liquid Biopsy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Liquid Biopsy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Liquid Biopsy Market
TABLE 72. List of primary sources, used in the study of global Liquid Biopsy Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Liquid Biopsy Market, research methodology
FIG 2. Global Liquid Biopsy Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Liquid Biopsy Market, key trends 2022
FIG 5. Global Liquid Biopsy Market, growth prospects 2023-2030
FIG 6. Global Liquid Biopsy Market, porters 5 force model
FIG 7. Global Liquid Biopsy Market, pest analysis
FIG 8. Global Liquid Biopsy Market, value chain analysis
FIG 9. Global Liquid Biopsy Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Liquid Biopsy Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Liquid Biopsy Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Liquid Biopsy Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Liquid Biopsy Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Liquid Biopsy Market, regional snapshot 2020 & 2030
FIG 15. North America Liquid Biopsy Market 2020 & 2030 (USD Billion)
FIG 16. Europe Liquid Biopsy Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Liquid Biopsy Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Liquid Biopsy Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Liquid Biopsy Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Liquid Biopsy Market, research methodology
FIG 2. Global Liquid Biopsy Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Liquid Biopsy Market, key trends 2022
FIG 5. Global Liquid Biopsy Market, growth prospects 2023-2030
FIG 6. Global Liquid Biopsy Market, porters 5 force model
FIG 7. Global Liquid Biopsy Market, pest analysis
FIG 8. Global Liquid Biopsy Market, value chain analysis
FIG 9. Global Liquid Biopsy Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Liquid Biopsy Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Liquid Biopsy Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Liquid Biopsy Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Liquid Biopsy Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Liquid Biopsy Market, regional snapshot 2020 & 2030
FIG 15. North America Liquid Biopsy Market 2020 & 2030 (USD Billion)
FIG 16. Europe Liquid Biopsy Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Liquid Biopsy Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Liquid Biopsy Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Liquid Biopsy Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
